Advanced Search

Study Preview



Study Title and Description

Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial.



Key Questions Addressed
6 Key Question 6. What is the effectiveness of currently recommended antiviral treatments in improving health outcomes in patients with HCV infection?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 or 6 infection (ENDURANCE-5,6): an open-label, multicentre, phase 3b trial.
Author Asselah T., Lee SS., Yao BB., Nguyen T., Wong F., Mahomed A., Lim SG., Abergel A., Sasadeusz J., Gane E., Zadeikis N., Schnell G., Zhang Z., Porcalla A., Mensa FJ., Nguyen K.
Country Centre de Recherche sur l'Inflammation, INSERM UMR 1149, Université Paris Diderot, Department of Hepatology, AP-HP Hôpital Beaujon, Clichy, France. Electronic address: tarik.asselah@aphp.fr.
Year 2019
Numbers Pubmed ID: 30393106

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.